ArticleExperimental hematology & oncology2026
Sequential therapy with decitabine and an XPO-1 inhibitor followed by allogeneic hematopoietic stem cell transplantation in MDS with biallelic TP53 inactivation patients : a preliminary case series.
Yanling Ren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.